How has been the historical performance of Hamps Bio?

Answer:The historical performance of Hamps Bio shows a mixed trend in its financial metrics over the past three years.

Breakdown:
Hamps Bio's net sales have increased from 5.58 Cr in Mar'23 to 6.67 Cr in Mar'25, indicating a steady growth in revenue. However, the total operating income has also risen in tandem, reflecting consistent performance. The raw material costs have surged to 0.85 Cr in Mar'25 from 0.21 Cr in Mar'23, while the purchase of finished goods decreased slightly to 2.01 Cr in Mar'25 from 2.17 Cr in Mar'24. Employee costs have risen, contributing to an overall increase in total expenditure, which reached 5.90 Cr in Mar'25 compared to 4.71 Cr in Mar'23. Operating profit (PBDIT) has shown fluctuations, peaking at 1.21 Cr in Mar'24 but dropping to 0.92 Cr in Mar'25. Profit before tax has also decreased from 0.65 Cr in Mar'24 to 0.40 Cr in Mar'25, leading to a profit after tax of 0.30 Cr in Mar'25, down from 0.50 Cr in Mar'24. The company's equity capital has significantly increased to 4.36 Cr in Mar'25 from 1.50 Cr in Mar'23, while total liabilities have risen to 12.67 Cr in Mar'25 from 3.61 Cr in Mar'22. The book value per share has improved to 20.2 in Mar'25 from 4.1875 in Mar'22, indicating a strengthening financial position despite the recent declines in profitability.